In this issue
Parental cancer and its effects on adolescents and their families
The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
Family functioning and adolescents' emotional and behavioral problems: when a parent has cancer
Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study
Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type
Polymorphisms in the genes of the urokinase plasminogen activation system in relation to colorectal cancer
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer
Systemic chemotherapy does not increase the risk of gastrointestinal perforation
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients
Pathology and clinical course of MALT lymphoma with plasmacytic differentiation
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases
Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment
Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation
Triple-negative breast cancer: MRI features in 29 patients
International expert consensus on radiotherapy of early breast cancer
International consensus on treatment of early breast cancer: radiotherapy issues
Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer
Oncology: a forgotten territory in Africa
subject index
author index